Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Implications of Compounds Designed to Inhibit ECM-Modifying Metalloproteinases
Authors
Keywords
-
Journal
PROTEOMICS
Volume 17, Issue 23-24, Pages 1600389
Publisher
Wiley
Online
2017-06-14
DOI
10.1002/pmic.201600389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9
- (2017) Todd C. Appleby et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Second Generation Triple-Helical Peptide Inhibitors of Matrix Metalloproteinases
- (2017) Manishabrata Bhowmick et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
- (2017) Jun Yong Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical benefit of INCB7839, a potent and selective ADAM inhibitor, in combination with trastuzumab in patients with metastatic HER2+ breast cancer.
- (2017) R. C. Newton et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis
- (2016) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors
- (2016) Hiroshi Nara et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell models
- (2016) Caterina Camodeca et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Glioblastoma multiforme targeted therapy: The Chlorotoxin story
- (2016) Or Cohen-Inbar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution
- (2016) Rugmani Padmanabhan Iyer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Molecular basis for the mechanism of action of an anti-TACE antibody
- (2016) Li Peng et al. mAbs
- Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses
- (2016) Ulrich Eckhard et al. MATRIX BIOLOGY
- Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study
- (2016) A. Winer et al. MOLECULAR CANCER THERAPEUTICS
- Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo
- (2016) Kenneth A. Botkjaer et al. Oncotarget
- A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models
- (2016) Jun Chen et al. Scientific Reports
- Harnessing the natural inhibitory domain to control TNFα Converting Enzyme (TACE) activity in vivo
- (2016) Eitan Wong et al. Scientific Reports
- Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function
- (2016) Peer-Hendrik Kuhn et al. eLife
- Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
- (2016) Franck Madoux et al. Scientific Reports
- ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets
- (2015) Daniela Dreymueller et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation
- (2015) Tobias Pasqualon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Adam17, a Target of Mir-326, Promotes Emt-Induced Cells Invasion in Lung Adenocarcinoma
- (2015) Ming Cai et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies
- (2015) Sabrina Amar et al. Expert Review of Proteomics
- SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes
- (2015) Anna M. Knapinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
- (2015) Peter G. Ruminski et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis
- (2015) Merry L. Lindsey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- Proteomic approaches to uncover MMP function
- (2015) Pascal Schlage et al. MATRIX BIOLOGY
- Matrix Metalloproteinase 10 Degradomics in Keratinocytes and Epidermal Tissue Identifies Bioactive Substrates With Pleiotropic Functions
- (2015) Pascal Schlage et al. MOLECULAR & CELLULAR PROTEOMICS
- A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways
- (2015) J. Rios-Doria et al. MOLECULAR CANCER THERAPEUTICS
- The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain
- (2015) Paul Saftig et al. PROGRESS IN NEUROBIOLOGY
- Monitoring matrix metalloproteinase activity at the epidermal-dermal interface by SILAC-iTRAQ-TAILS
- (2015) Pascal Schlage et al. PROTEOMICS
- ADAM8 as a drug target in pancreatic cancer
- (2015) Uwe Schlomann et al. Nature Communications
- CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases
- (2015) Hina Mir et al. Oncotarget
- Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy
- (2015) Eleanor I. Ager et al. JNCI-Journal of the National Cancer Institute
- ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
- (2015) Maria Raffaella Zocchi et al. OncoImmunology
- Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer
- (2015) Derek C. Marshall et al. PLoS One
- ADAM10 and ADAM17: New Players in Trastuzumab Resistance
- (2015) Michael J. Duffy et al. Oncotarget
- Citrate Synthase Is a Novel In Vivo Matrix Metalloproteinase-9 Substrate That Regulates Mitochondrial Function in the Postmyocardial Infarction Left Ventricle
- (2014) Lisandra E. de Castro Brás et al. ANTIOXIDANTS & REDOX SIGNALING
- Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space
- (2014) J. Pruessmeyer et al. BLOOD
- Merging Allosteric and Active Site Binding Motifs: De novo Generation of Target Selectivity and Potency via Natural-Product-Derived Fragments
- (2014) Jan Lanz et al. ChemMedChem
- P95 HER2 fragments and breast cancer outcome
- (2014) Deniz Tural et al. Expert Review of Anticancer Therapy
- Targeting the Sheddase Activity of ADAM17 by an Anti-ADAM17 Antibody D1(A12) Inhibits Head and Neck Squamous Cell Carcinoma Cell Proliferation and Motility via Blockage of Bradykinin Induced HERs Transactivation
- (2014) Yanchao Huang et al. International Journal of Biological Sciences
- Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro
- (2014) Timothy P. Spicer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach
- (2014) Hiroshi Nara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Deciphering the Role of the ADAM17-Dependent Secretome in Cell Signaling
- (2014) Rebeca Kawahara et al. JOURNAL OF PROTEOME RESEARCH
- LC–MS Based Cleavage Site Profiling of the Proteases ADAM10 and ADAM17 Using Proteome-Derived Peptide Libraries
- (2014) Joanna Tucher et al. JOURNAL OF PROTEOME RESEARCH
- ADAM17 silencing suppresses the migration and invasion of non-small cell lung cancer
- (2014) XIAOHONG LV et al. Molecular Medicine Reports
- Is there new hope for therapeutic matrix metalloproteinase inhibition?
- (2014) Roosmarijn E. Vandenbroucke et al. NATURE REVIEWS DRUG DISCOVERY
- Remodelling the extracellular matrix in development and disease
- (2014) Caroline Bonnans et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Development of a ‘mouse and human cross-reactive’ affinity-matured exosite inhibitory human antibody specific to TACE (ADAM17) for cancer immunotherapy
- (2014) Hang Fai Kwok et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis
- (2014) Caroline L. Bellac et al. Cell Reports
- NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
- (2013) R. Romee et al. BLOOD
- Strategic Targeting of Multiple Water-Mediated Interactions: A Concise and Rational Structure-Based Design Approach to Potent and Selective MMP-13 Inhibitors
- (2013) Thomas Fischer et al. ChemMedChem
- Time-resolved Analysis of the Matrix Metalloproteinase 10 Substrate Degradome
- (2013) Pascal Schlage et al. MOLECULAR & CELLULAR PROTEOMICS
- ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival
- (2013) Shuang-Shuang Ni et al. TUMOR BIOLOGY
- Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
- (2013) Elin Hadler-Olsen et al. TUMOR BIOLOGY
- Development of a Neutralizing Antibody Specific for the Active Form of Matrix Metalloproteinase-13
- (2012) Shoichi Naito et al. BIOCHEMISTRY
- Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
- (2012) Dmitriy Minond et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway
- (2012) JIANLI GUO et al. ONCOLOGY REPORTS
- An MMP13-Selective Inhibitor Delays Primary Tumor Growth and the Onset of Tumor-Associated Osteolytic Lesions in Experimental Models of Breast Cancer
- (2012) Manisha Shah et al. PLoS One
- Anti-Tumour Effects of a Specific Anti-ADAM17 Antibody in an Ovarian Cancer Model In Vivo
- (2012) Frances M. Richards et al. PLoS One
- A potential new target for asthma therapy: A Disintegrin and Metalloprotease 10 (ADAM10) involvement in murine experimental asthma
- (2011) J. A. Mathews et al. ALLERGY
- Proteases involved in cartilage matrix degradation in osteoarthritis
- (2011) Linda Troeberg et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds
- (2011) Joshua Roth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures
- (2011) Charlotte Morrison et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Evaluation of a Non-Zn Chelating, Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitor for Potential Intra-articular Treatment of Osteoarthritis
- (2011) Christian Gege et al. JOURNAL OF MEDICINAL CHEMISTRY
- Human matrix metalloproteinases: An ubiquitarian class of enzymes involved in several pathological processes
- (2011) Diego Sbardella et al. MOLECULAR ASPECTS OF MEDICINE
- Cross-domain inhibition of TACE ectodomain
- (2011) C. J. Tape et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability
- (2010) Donghong Amy Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Clinical Benefit of INCB7839, a Potent and Selective Inhibitor of ADAM10 and ADAM17, in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer Patients.
- (2010) S. Friedman et al. CANCER RESEARCH
- Temporal and Spatial Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Following Myocardial Infarction
- (2010) Merry L. Lindsey et al. Cardiovascular Therapeutics
- Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases
- (2010) Bénédicte Cauwe et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
- (2010) Athena Chalaris et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Broad Coverage Identification of Multiple Proteolytic Cleavage Site Sequences in Complex High Molecular Weight Proteins Using Quantitative Proteomics as a Complement to Edman Sequencing
- (2010) Alain Doucet et al. MOLECULAR & CELLULAR PROTEOMICS
- Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction
- (2010) Rogelio Zamilpa et al. PROTEOMICS
- Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis
- (2009) A. Jungel et al. ANNALS OF THE RHEUMATIC DISEASES
- A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models
- (2009) Vijaykumar M. Baragi et al. ARTHRITIS AND RHEUMATISM
- Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10
- (2009) Cristina I. Caescu et al. BIOCHEMICAL JOURNAL
- Updated Biological Roles for Matrix Metalloproteinases and New “Intracellular” Substrates Revealed by Degradomics
- (2009) Georgina S. Butler et al. BIOCHEMISTRY
- Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-α
- (2009) Atsuhiko Hikita et al. Biochemistry and Cell Biology
- Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors
- (2009) Alexander Heim-Riether et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition
- (2009) David M. Burns et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel selective HER-2 sheddase inhibitors through optimization of P1 moiety
- (2009) Yun-Long Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- High throughput analysis of proteins associating with a proinvasive MT1-MMP in human malignant melanoma A375 cells
- (2009) Taizo Tomari et al. CANCER SCIENCE
- Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants
- (2009) Dorothea Piecha et al. INFLAMMATION RESEARCH
- The Study of the Inhibition of the Recombinant TACE Prodomain to Endotoxemia in Mice
- (2009) Xiaoou Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression of ADAMs (“a disintegrin and metalloprotease”) in the human lung
- (2009) Antoon Dijkstra et al. VIRCHOWS ARCHIV
- Specific targeting of metzincin family members with small-molecule inhibitors: Progress toward a multifarious challenge
- (2008) Dimitris Georgiadis et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate
- (2008) Janelle L. Lauer-Fields et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Plasma MMP1 and MMP8 expression in breast cancer: Protective role of MMP8 against lymph node metastasis
- (2008) Julie Decock et al. BMC CANCER
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
- (2008) L. Witters et al. CANCER RESEARCH
- Quinazolinones and Pyrido[3,4-d]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis
- (2008) Jie Jack Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach
- (2008) Danmei Xu et al. MOLECULAR & CELLULAR PROTEOMICS
- Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding
- (2008) G. S. Butler et al. MOLECULAR AND CELLULAR BIOLOGY
- The ADAM metalloproteinases
- (2008) D EDWARDS et al. MOLECULAR ASPECTS OF MEDICINE
- Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis
- (2008) Marcia L Moss et al. Nature clinical practice. Rheumatology
- Design and identification of selective HER-2 sheddase inhibitors via P1′ manipulation and unconventional P2′ perturbations to induce a molecular metamorphosis
- (2007) Wenqing Yao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle permutations
- (2007) David M. Burns et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now